Cyanosis MRI

Revision as of 20:14, 29 January 2021 by Caroline Collis (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Cyanosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cyanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cyanosis MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cyanosis MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cyanosis MRI

CDC on Cyanosis MRI

Cyanosis MRI in the news

Blogs on Cyanosis MRI

Directions to Hospitals Treating Cyanosis

Risk calculators and risk factors for Cyanosis MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Amandeep Singh M.D.[3]

Overview

Cardiac MRI is noninvasive imaging for the evaluation of cyanotic congenital heart disease and determines myocardial function and area of fibrosis, the direction of flow and velocity across the palliative shunt and valves, the anomaly of connection of arteries and veins and correlation of anatomic and morphologic ventricles with great arteries in complex congenital heart disease.

MRI

A cardiac MRI is a useful tool for diagnostic of cyanotic congenital heart disease. Findings on a cardiac MRI in cyanotic congenital heart disease include:[1]


Recommendation for Cardiac MRI(CMR)imaging in congenital heart disease according to 2018AHA/ACC Guideline

Class OF Recommendation Level Of Evidence Recommendations
B Serial CMR for assessment of right ventricle enlargement and dysfunction in congenital heart disease who are at risk
॥a C Initial evaluation and serial assessment of congenital heart disease based on complexity and anatomy

References

  1. Sreedhar, CM; Ram, MN Sree; Alam, A; Indrajit, IK (2005). "Cardiac MRI in Congenital Heart Disease – Our Experience". Medical Journal Armed Forces India. 61 (1): 57–62. doi:10.1016/S0377-1237(05)80122-4. ISSN 0377-1237.